Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance
Abstract Pulmonary hypertension (PH) is a prevalent comorbidity associated with COPD accountable for increased mortality, exacerbation frequency, and progressive clinical course. Studies examining pulmonary vasodilator therapy in COPD-PH have shown mixed results, likely due to the heterogenous natur...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-02-01
|
| Col·lecció: | BMC Pulmonary Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12890-026-04203-4 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|